Irritable bowel syndrome (IBS) Digestive System
Conditions
Interventions
All participants will receive a 12-week course of Symprove (70 ml per day), a water-based solution that contains billions of live and active bacteria. Participants will also complete study surveys at
Sponsors
Symprove Ltd
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Adults (18-75 years) in the UK who have IBS, either self-diagnosed or medically diagnosed 2. Experiencing regular symptoms related to IBS (e.g., tummy pain, constipation, diarrhoea, bloating)
Exclusion criteria
Exclusion criteria: 1. Currently taking probiotics or prebiotics supplements (e.g. Bimuno) or yogurts containing probiotics (e.g., Yakult, Actimel) 3. Taken Symprove in the last 3 months 4. Taken antibiotics in the last 4 weeks 5. Diagnosed with gut conditions other than Irritable Bowel Syndrome, such as inflammatory bowel disease (e.g., Crohn’s disease or ulcerative colitis), coeliac disease, hepatitis, gallstones, acid reflux/dyspepsia 6. Received gastrointestinal surgery, cancer treatment or been hospitalised in the last 6 months 7. Diagnosed with any significant or unstable psychological issues (such as depression, bipolar illness, psychosis) 8. Diagnosed with any significant heart, lung or kidney issues 9. Currently pregnant or breastfeeding 10. Patients taking part in other interventional research where they are receiving treatment
Countries
England, United Kingdom
Contacts
Public ContactLauren Hayman
Outcome results
None listed